December 15, 2005 / Research Triangle Park, NC — Clinipace, Inc., a software company focused on late-stage clinical research studies and patient registries, and TrialCard, Inc., a pharmaceutical marketing services company specializing in alternative prescription drug sampling, today announced a strategic partnership to develop and market innovative solutions to increase and simplify patient and physician participation in phase IV clinical studies and sponsored patient registries.
The partners plan to develop solutions based on the combination of Clinipace’s powerful clinical research software platform – Tempo – and TrialCard’s drug sample card technology. Together, these solutions will streamline the logistics – from enrollment to fulfillment – of phase IV studies and sponsored registries, all while increasing physician and patient participation.
Physicians will be able to instantly enroll consenting patients into drug registries at the point-of-care by simply providing the patient a drug sample card that can be swiped in any physician’s credit card machine – initializing enrollment.
Furthermore, this partnership, and its resulting services, will enable pharmaceutical companies to save time and money by eliminating the need for a third-party drug fulfillment vendor in phase IV studies. For phase IV studies, pharmaceutical companies must take costly and time-intensive measures to deliver prescription drugs to its study subjects. However, this partnership will introduce solutions that allow participants to fulfill their prescriptions at any pharmacy.
“We are focused on creating solutions that deliver efficiencies in phase IV clinical studies and registries by reducing or eliminating friction points throughout their lifecycle,” said Jeff Williams, Chief Executive Officer of Clinipace. “For registries, this merging of technologies will increase physician and patient participation by reducing the enrollment burden placed on physicians who participate in these projects.”
“Our solutions will allow pharmaceutical companies to learn more about the use of medication in any study, including drug and patient registries, post-marketing surveillance studies, and appropriate use studies,” according to David Cunningham, TrialCard President and CEO. “We are very excited about this partnership and expect to announce new products supporting this initiative in the near future.”
Clinipace is a clinical research software company providing a single, integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies, Clinical Research Organizations (CROs) and Academic Medical Centers (AMCs). Our platform, called Tempo, is delivered via a web-based, on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms, reducing project efforts and costs from startup to conclusion, and empowering project stakeholders to make informed real-time decisions regarding their research. For more information on Clinipace, please visit: www.clinipace.com
Headquartered in Cary, NC, TrialCard Inc. is an alternative prescription sampling company that specializes in the implementation of marketing programs utilizing its patented sampling technology in direct-to-physician, direct-to-consumer, loyalty programs, registry, clinical trials and patient assistance programs. Additional information on TrialCard, Inc. can be found at www.trialcard.com.